Effects of enoxaparin on late pregnancy complications and neonatal outcome in women with recurrent pregnancy loss and thrombophilia: results from the Live-Enox study
Open Access
- 30 September 2005
- journal article
- research article
- Published by Elsevier BV in Fertility and Sterility
- Vol. 84 (3), 770-773
- https://doi.org/10.1016/j.fertnstert.2005.03.048
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE‐ENOX studyJournal of Thrombosis and Haemostasis, 2004
- Clinical management of thrombophilia-related placental vascular complicationsBlood, 2004
- Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorderBlood, 2004
- Inherited thrombophilia and pregnancy lossBest Practice & Research Clinical Haematology, 2003
- Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophiliaJournal of Thrombosis and Haemostasis, 2003
- The use of low-molecular-weight heparin for the management of venous thromboembolism in pregnancyEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2002
- Enoxaparin Sodium Improves Pregnancy Outcome in Aspirin-resistant Antiphospholipid/Antiprotein Antibody SyndromesThrombosis and Haemostasis, 2002
- Gestational Outcome in Thrombophilic Women with Recurrent Pregnancy Loss Treated by EnoxaparinThrombosis and Haemostasis, 2000
- Increased Frequency of Genetic Thrombophilia in Women with Complications of PregnancyThe New England Journal of Medicine, 1999
- Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)BMJ, 1997